-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
89bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- 89bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$57.3 M, a 101% decline year-over-year.
- 89bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$180 M, a 70.3% decline year-over-year.
- 89bio, Inc. annual Operating Income (Loss) for 2023 was -$151 M, a 47.9% decline from 2022.
- 89bio, Inc. annual Operating Income (Loss) for 2022 was -$102 M, a 13.9% decline from 2021.
- 89bio, Inc. annual Operating Income (Loss) for 2021 was -$89.7 M, a 81.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)